(Total Views: 220)
Posted On: 06/28/2017 7:14:47 AM
Post# of 23071
$RNVA,,,Fitz, this stock chart looks great and ready for a nice rip. Volume early was great and had a nice rip. Volume at end of day looked really good as well. RSI , Macd and Stochastics look good and I wouldn't be surprised that this will be a great buy. Thanks, great find!
June 27, 2017 Rennova Health, Inc. (RNVA), (RNVAZ) a vertically integrated provider of industry-leading diagnostics and supportive software solutions for healthcare providers, announced an agreement between its subsidiary Advanced Molecular Services Group, Inc. (AMS Group) and Certainty Health, LLC, a pioneer in cloud-based mobile applications for patient-focused health information. The partnership will develop next generation smartphone tools to enable patients, families, and their healthcare teams to confidently assess the importance of a patients’ genetic background in treatment decisions for various psychiatric diseases.
“We look forward to working with Rennova Health to expand a mobile precision medicine platform to immediately address the unmet needs of patients and their caregivers for relevant molecular information impacting psychiatry today,” stated Dr. Chris Yoo, President and COO of Certainty Health. “Rennova’s incredibly rich and growing databases of pharmacogenomic drug metabolism data represents over a decade of real-world diagnostic results for multiple diseases and together with Rennova, we will democratize access to this knowledge for the benefit of patients.”
Rennova Health, Inc. (:RNVA)‘s market cap, the total dollar value of all of their outstanding shares, is 2.77m. Including today’s unusual volume, Rennova Health, Inc.‘s stock is performing at -84.34% on the year. For the week, the stock is performing 8.30%. Over the past month the firm’s stock is -23.53%, -79.03% for the last quarter, -84.95% for the past six-months and -98.09% for the last year.
Current levels places Rennova Health, Inc. (:RNVA)’s stock about -61.96% from the 50-day high and 56.25% away from the 50-day low.
June 27, 2017 Rennova Health, Inc. (RNVA), (RNVAZ) a vertically integrated provider of industry-leading diagnostics and supportive software solutions for healthcare providers, announced an agreement between its subsidiary Advanced Molecular Services Group, Inc. (AMS Group) and Certainty Health, LLC, a pioneer in cloud-based mobile applications for patient-focused health information. The partnership will develop next generation smartphone tools to enable patients, families, and their healthcare teams to confidently assess the importance of a patients’ genetic background in treatment decisions for various psychiatric diseases.
“We look forward to working with Rennova Health to expand a mobile precision medicine platform to immediately address the unmet needs of patients and their caregivers for relevant molecular information impacting psychiatry today,” stated Dr. Chris Yoo, President and COO of Certainty Health. “Rennova’s incredibly rich and growing databases of pharmacogenomic drug metabolism data represents over a decade of real-world diagnostic results for multiple diseases and together with Rennova, we will democratize access to this knowledge for the benefit of patients.”
Rennova Health, Inc. (:RNVA)‘s market cap, the total dollar value of all of their outstanding shares, is 2.77m. Including today’s unusual volume, Rennova Health, Inc.‘s stock is performing at -84.34% on the year. For the week, the stock is performing 8.30%. Over the past month the firm’s stock is -23.53%, -79.03% for the last quarter, -84.95% for the past six-months and -98.09% for the last year.
Current levels places Rennova Health, Inc. (:RNVA)’s stock about -61.96% from the 50-day high and 56.25% away from the 50-day low.
(0)
(0)
'Everything works out in the end,,,If it hasn't worked out,,it's not the end'
https://twitter.com/twitter/statuses/957208055766241280
https://twitter.com/twitter/statuses/957208055766241280
